Klaria Pharma Holding AB (OSTO:KLAR) FFO


OSTO:KLAR Klaria Pharma Holding AB OSTO:KLAR
28 GF Score
Price kr0.78
GF Value kr0.32
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Klaria Pharma Holding AB FFO?

FFO (Funds from operations) only applies to REITs.

OSTO:KLAR
28GF Score
Klaria Pharma Holding AB OSTO:KLAR
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Klaria Pharma Holding AB (OSTO:KLAR) Overvalued in 2026?

Based on GuruFocus' analysis, Klaria Pharma Holding AB stock appears to be overvalued. The current stock price of kr0.78 is trading 143.8% above its estimated GF Value™ of kr0.32. GuruFocus considers Klaria Pharma Holding AB to be Significantly Overvalued.

Key valuation signals for OSTO:KLAR:

  • FFO:
  • GF Value™: kr0.32 vs. price of kr0.78 (143.8% above fair value)
  • GF Score™: 28/100 with 6 warning signs

No single metric tells the full story. See the OSTO:KLAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Klaria Pharma Holding AB Business Description

Other Exchanges 6FN:Germany
Address Virdings Alle 2, Uppsala, CHE, 754 50
Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product's active substance through the oral mucosa.
28GF Score

Get the complete analysis for OSTO:KLAR

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.78
Price
kr0.32
GF Value